Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2018-12

AUTHORS

Elen Kristine Höglander, Silje Nord, David C. Wedge, Ole Christian Lingjærde, Laxmi Silwal-Pandit, Hedda vdL Gythfeldt, Hans Kristian Moen Vollan, Thomas Fleischer, Marit Krohn, Ellen Schlitchting, Elin Borgen, Øystein Garred, Marit M. Holmen, Erik Wist, Bjørn Naume, Peter Van Loo, Anne-Lise Børresen-Dale, Olav Engebraaten, Vessela Kristensen

ABSTRACT

BACKGROUND: Chemotherapeutic agents such as anthracyclines and taxanes are commonly used in the neoadjuvant setting. Bevacizumab is an antibody which binds to vascular endothelial growth factor A (VEGFA) and inhibits its receptor interaction, thus obstructing the formation of new blood vessels. METHODS: A phase II randomized clinical trial of 123 patients with Her2-negative breast cancer was conducted, with patients treated with neoadjuvant chemotherapy (fluorouracil (5FU)/epirubicin/cyclophosphamide (FEC) and taxane), with or without bevacizumab. Serial biopsies were obtained at time of diagnosis, after 12 weeks of treatment with FEC ± bevacizumab, and after 25 weeks of treatment with taxane ± bevacizumab. A time course study was designed to investigate the genomic landscape at the three time points when tumor DNA alterations, tumor percentage, genomic instability, and tumor clonality were assessed. Substantial differences were observed with some tumors changing mainly between diagnosis and at 12 weeks, others between 12 and 25 weeks, and still others changing in both time periods. RESULTS: In both treatment arms, good responders (GR) and non-responders (NR) displayed significant difference in genomic instability index (GII) at time of diagnosis. In the combination arm, copy number alterations at 25 loci at the time of diagnosis were significantly different between the GR and NR. An inverse aberration pattern was also observed between the two extreme response groups at 6p22-p12 for patients in the combination arm. Signs of subclonal reduction were observed, with some aberrations disappearing and others being retained during treatment. Increase in subclonal amplification was observed at 6p21.1, a locus which contains the VEGFA gene for the protein which are targeted by the study drug bevacizumab. Of the 13 pre-treatment samples that had a gain at VEGFA, 12 were responders. Significant decrease of frequency of subclones carrying gains at 17q21.32-q22 was observed at 12 weeks, with the peak occurring at TMEM100, an ALK1 receptor signaling-dependent gene essential for vasculogenesis. This implies that cells bearing amplifications of VEGFA and TMEM100 are particularly sensitive to this treatment regime. CONCLUSIONS: Taken together, these results suggest that heterogeneity and subclonal architecture influence the response to targeted treatment in combination with chemotherapy, with possible implications for clinical decision-making and monitoring of treatment efficacy. TRIAL REGISTRATION: NCT00773695 . Registered 15 October 2008. More... »

PAGES

92

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s13073-018-0601-y

DOI

http://dx.doi.org/10.1186/s13073-018-0601-y

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1110268606

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30497530


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Angiogenesis Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bevacizumab", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Breast Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Proliferation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Genomic Instability", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoadjuvant Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vascular Endothelial Growth Factor A", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Oslo University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.55325.34", 
          "name": [
            "Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Postboks 4953 Nydalen, 0424, Oslo, Norway", 
            "KG Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway"
          ], 
          "type": "Organization"
        }, 
        "familyName": "H\u00f6glander", 
        "givenName": "Elen Kristine", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Oslo University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.55325.34", 
          "name": [
            "Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Postboks 4953 Nydalen, 0424, Oslo, Norway", 
            "KG Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nord", 
        "givenName": "Silje", 
        "id": "sg:person.01101476162.97", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01101476162.97"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Oxford", 
          "id": "https://www.grid.ac/institutes/grid.4991.5", 
          "name": [
            "Big Data Institute, University of Oxford, Oxford, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wedge", 
        "givenName": "David C.", 
        "id": "sg:person.01252077430.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01252077430.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "KG Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway", 
            "Biomedical Informatics, Department of Informatics and Centre for Cancer Biomedicine, University of Oslo, Oslo, Norway"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lingj\u00e6rde", 
        "givenName": "Ole Christian", 
        "id": "sg:person.0707212713.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707212713.81"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Oslo University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.55325.34", 
          "name": [
            "Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Postboks 4953 Nydalen, 0424, Oslo, Norway", 
            "KG Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Silwal-Pandit", 
        "givenName": "Laxmi", 
        "id": "sg:person.01047355062.84", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01047355062.84"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Oslo University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.55325.34", 
          "name": [
            "Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Postboks 4953 Nydalen, 0424, Oslo, Norway", 
            "Department of Oncology, Oslo University Hospital, 0407, Oslo, Norway"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gythfeldt", 
        "givenName": "Hedda vdL", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Oslo University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.55325.34", 
          "name": [
            "Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Postboks 4953 Nydalen, 0424, Oslo, Norway", 
            "KG Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway", 
            "Department of Oncology, Oslo University Hospital, 0407, Oslo, Norway"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vollan", 
        "givenName": "Hans Kristian Moen", 
        "id": "sg:person.01170302532.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01170302532.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Oslo University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.55325.34", 
          "name": [
            "Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Postboks 4953 Nydalen, 0424, Oslo, Norway", 
            "KG Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fleischer", 
        "givenName": "Thomas", 
        "id": "sg:person.01044522050.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01044522050.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Oslo University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.55325.34", 
          "name": [
            "Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Postboks 4953 Nydalen, 0424, Oslo, Norway", 
            "KG Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Krohn", 
        "givenName": "Marit", 
        "id": "sg:person.0624011275.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0624011275.27"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Oslo University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.55325.34", 
          "name": [
            "Section for Breast and Endocrine Surgery, Oslo University Hospital, Oslo, Norway"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schlitchting", 
        "givenName": "Ellen", 
        "id": "sg:person.07412247627.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07412247627.28"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Oslo University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.55325.34", 
          "name": [
            "Department of Pathology, Oslo University Hospital, Oslo, Norway"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Borgen", 
        "givenName": "Elin", 
        "id": "sg:person.01062455314.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01062455314.30"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Oslo University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.55325.34", 
          "name": [
            "Department of Pathology, Oslo University Hospital, Oslo, Norway"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Garred", 
        "givenName": "\u00d8ystein", 
        "id": "sg:person.01050747741.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050747741.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Oslo University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.55325.34", 
          "name": [
            "Department of Radiology, Oslo University Hospital, Oslo, Norway"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Holmen", 
        "givenName": "Marit M.", 
        "id": "sg:person.01267735562.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01267735562.34"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Oslo University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.55325.34", 
          "name": [
            "Department of Oncology, Oslo University Hospital, 0407, Oslo, Norway"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wist", 
        "givenName": "Erik", 
        "id": "sg:person.01245337432.67", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01245337432.67"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Oslo University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.55325.34", 
          "name": [
            "KG Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway", 
            "Department of Oncology, Oslo University Hospital, 0407, Oslo, Norway"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Naume", 
        "givenName": "Bj\u00f8rn", 
        "id": "sg:person.01071554513.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01071554513.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Francis Crick Institute", 
          "id": "https://www.grid.ac/institutes/grid.451388.3", 
          "name": [
            "Cancer Research UK London Research Institute, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Van Loo", 
        "givenName": "Peter", 
        "id": "sg:person.01017630143.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017630143.46"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Oslo University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.55325.34", 
          "name": [
            "Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Postboks 4953 Nydalen, 0424, Oslo, Norway", 
            "KG Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway"
          ], 
          "type": "Organization"
        }, 
        "familyName": "B\u00f8rresen-Dale", 
        "givenName": "Anne-Lise", 
        "id": "sg:person.01361622203.97", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01361622203.97"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Oslo University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.55325.34", 
          "name": [
            "KG Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway", 
            "Department of Oncology, Oslo University Hospital, 0407, Oslo, Norway"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Engebraaten", 
        "givenName": "Olav", 
        "id": "sg:person.01002504604.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01002504604.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Oslo", 
          "id": "https://www.grid.ac/institutes/grid.5510.1", 
          "name": [
            "Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Postboks 4953 Nydalen, 0424, Oslo, Norway", 
            "KG Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway", 
            "Department of Clinical Molecular Biology (EpiGen), Divison of Medicine, Akershus University Hospital, L\u00f8renskog, Norway", 
            "Institute of Clinical Medicine, University of Oslo, Oslo, Norway"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kristensen", 
        "givenName": "Vessela", 
        "id": "sg:person.01215000714.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01215000714.10"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1073/pnas.1009843107", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007646723"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1471-2164-13-591", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010110271", 
          "https://doi.org/10.1186/1471-2164-13-591"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6600210", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010544058", 
          "https://doi.org/10.1038/sj.bjc.6600210"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6600210", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010544058", 
          "https://doi.org/10.1038/sj.bjc.6600210"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/s10434-011-2108-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011255060", 
          "https://doi.org/10.1245/s10434-011-2108-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.cell.2012.04.023", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012547698"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2014.57.0572", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014185899"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1111097", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014405968"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature10983", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014607335", 
          "https://doi.org/10.1038/nature10983"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1383/surg.21.11.272.22295", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014763252"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdt361", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014803302"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdu118", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015330592"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(03)14023-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017992521"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.2013.634", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023376159", 
          "https://doi.org/10.1038/bjc.2013.634"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/labinvest.2013.128", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027726525", 
          "https://doi.org/10.1038/labinvest.2013.128"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pone.0108405", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029744734"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1096/fj.02-0329fje", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030415329"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.1136678", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031480762"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6603143", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033429494", 
          "https://doi.org/10.1038/sj.bjc.6603143"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6603143", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033429494", 
          "https://doi.org/10.1038/sj.bjc.6603143"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-04-2421", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038294800"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.onc.1201380", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038979818", 
          "https://doi.org/10.1038/sj.onc.1201380"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.onc.1201380", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038979818", 
          "https://doi.org/10.1038/sj.onc.1201380"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-12-3029", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042897668"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/cad.0b013e32833b7598", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043826280"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/cad.0b013e32833b7598", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043826280"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.18.1370", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045851448"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm.3886", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046110380", 
          "https://doi.org/10.1038/nm.3886"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrm1357", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052442189", 
          "https://doi.org/10.1038/nrm1357"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrm1357", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052442189", 
          "https://doi.org/10.1038/nrm1357"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3892/or.14.2.513", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071529632"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1999.17.2.460", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074265640"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-17-0160", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1085376969"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-12", 
    "datePublishedReg": "2018-12-01", 
    "description": "BACKGROUND: Chemotherapeutic agents such as anthracyclines and taxanes are commonly used in the neoadjuvant setting. Bevacizumab is an antibody which binds to vascular endothelial growth factor A (VEGFA) and inhibits its receptor interaction, thus obstructing the formation of new blood vessels.\nMETHODS: A phase II randomized clinical trial of 123 patients with Her2-negative breast cancer was conducted, with patients treated with neoadjuvant chemotherapy (fluorouracil (5FU)/epirubicin/cyclophosphamide (FEC) and taxane), with or without bevacizumab. Serial biopsies were obtained at time of diagnosis, after 12\u2009weeks of treatment with FEC \u00b1 bevacizumab, and after 25\u2009weeks of treatment with taxane \u00b1 bevacizumab. A time course study was designed to investigate the genomic landscape at the three time points when tumor DNA alterations, tumor percentage, genomic instability, and tumor clonality were assessed. Substantial differences were observed with some tumors changing mainly between diagnosis and at 12\u2009weeks, others between 12 and 25\u2009weeks, and still others changing in both time periods.\nRESULTS: In both treatment arms, good responders (GR) and non-responders (NR) displayed significant difference in genomic instability index (GII) at time of diagnosis. In the combination arm, copy number alterations at 25 loci at the time of diagnosis were significantly different between the GR and NR. An inverse aberration pattern was also observed between the two extreme response groups at 6p22-p12 for patients in the combination arm. Signs of subclonal reduction were observed, with some aberrations disappearing and others being retained during treatment. Increase in subclonal amplification was observed at 6p21.1, a locus which contains the VEGFA gene for the protein which are targeted by the study drug bevacizumab. Of the 13 pre-treatment samples that had a gain at VEGFA, 12 were responders. Significant decrease of frequency of subclones carrying gains at 17q21.32-q22 was observed at 12\u2009weeks, with the peak occurring at TMEM100, an ALK1 receptor signaling-dependent gene essential for vasculogenesis. This implies that cells bearing amplifications of VEGFA and TMEM100 are particularly sensitive to this treatment regime.\nCONCLUSIONS: Taken together, these results suggest that heterogeneity and subclonal architecture influence the response to targeted treatment in combination with chemotherapy, with possible implications for clinical decision-making and monitoring of treatment efficacy.\nTRIAL REGISTRATION: NCT00773695 . Registered 15 October 2008.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s13073-018-0601-y", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1040124", 
        "issn": [
          "1756-994X"
        ], 
        "name": "Genome Medicine", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "10"
      }
    ], 
    "name": "Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations", 
    "pagination": "92", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "59796af2b93074086591514be1e031840f09caf58588fc7197ff1ece353ce038"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30497530"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101475844"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s13073-018-0601-y"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1110268606"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s13073-018-0601-y", 
      "https://app.dimensions.ai/details/publication/pub.1110268606"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T12:52", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000364_0000000364/records_72835_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs13073-018-0601-y"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s13073-018-0601-y'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s13073-018-0601-y'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s13073-018-0601-y'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s13073-018-0601-y'


 

This table displays all metadata directly associated to this object as RDF triples.

346 TRIPLES      21 PREDICATES      67 URIs      31 LITERALS      19 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s13073-018-0601-y schema:about N1a2d6c899d6e4437aa826f9f65b38bbd
2 N33eb901592ab402794857c701df7d797
3 N3f913dea795640f9a7334bdf50ec5011
4 N5e12142cf51646608aeeb0fb26daf50b
5 N8205dc5d61824bf0a56e425cd155d780
6 N86046546508740a1b978c6fab50801b4
7 N8f1ed808a59e43228fa6c42c5c79bf45
8 Nb16e70d4515f472ba97c130156228c08
9 Ndd6f211119f0412fade052bcef8b1333
10 Nf9ad958fa8aa4c2dae2a08596873822c
11 anzsrc-for:11
12 anzsrc-for:1112
13 schema:author Nfdc0c657c8de43b0b90da9ef3dffde48
14 schema:citation sg:pub.10.1038/bjc.2013.634
15 sg:pub.10.1038/labinvest.2013.128
16 sg:pub.10.1038/nature10983
17 sg:pub.10.1038/nm.3886
18 sg:pub.10.1038/nrm1357
19 sg:pub.10.1038/sj.bjc.6600210
20 sg:pub.10.1038/sj.bjc.6603143
21 sg:pub.10.1038/sj.onc.1201380
22 sg:pub.10.1186/1471-2164-13-591
23 sg:pub.10.1245/s10434-011-2108-2
24 https://doi.org/10.1016/j.cell.2012.04.023
25 https://doi.org/10.1016/s0140-6736(03)14023-8
26 https://doi.org/10.1056/nejmoa1111097
27 https://doi.org/10.1073/pnas.1009843107
28 https://doi.org/10.1093/annonc/mdt361
29 https://doi.org/10.1093/annonc/mdu118
30 https://doi.org/10.1096/fj.02-0329fje
31 https://doi.org/10.1097/cad.0b013e32833b7598
32 https://doi.org/10.1126/science.1136678
33 https://doi.org/10.1158/1078-0432.ccr-04-2421
34 https://doi.org/10.1158/1078-0432.ccr-12-3029
35 https://doi.org/10.1158/1078-0432.ccr-17-0160
36 https://doi.org/10.1200/jco.1999.17.2.460
37 https://doi.org/10.1200/jco.2008.18.1370
38 https://doi.org/10.1200/jco.2014.57.0572
39 https://doi.org/10.1371/journal.pone.0108405
40 https://doi.org/10.1383/surg.21.11.272.22295
41 https://doi.org/10.3892/or.14.2.513
42 schema:datePublished 2018-12
43 schema:datePublishedReg 2018-12-01
44 schema:description BACKGROUND: Chemotherapeutic agents such as anthracyclines and taxanes are commonly used in the neoadjuvant setting. Bevacizumab is an antibody which binds to vascular endothelial growth factor A (VEGFA) and inhibits its receptor interaction, thus obstructing the formation of new blood vessels. METHODS: A phase II randomized clinical trial of 123 patients with Her2-negative breast cancer was conducted, with patients treated with neoadjuvant chemotherapy (fluorouracil (5FU)/epirubicin/cyclophosphamide (FEC) and taxane), with or without bevacizumab. Serial biopsies were obtained at time of diagnosis, after 12 weeks of treatment with FEC ± bevacizumab, and after 25 weeks of treatment with taxane ± bevacizumab. A time course study was designed to investigate the genomic landscape at the three time points when tumor DNA alterations, tumor percentage, genomic instability, and tumor clonality were assessed. Substantial differences were observed with some tumors changing mainly between diagnosis and at 12 weeks, others between 12 and 25 weeks, and still others changing in both time periods. RESULTS: In both treatment arms, good responders (GR) and non-responders (NR) displayed significant difference in genomic instability index (GII) at time of diagnosis. In the combination arm, copy number alterations at 25 loci at the time of diagnosis were significantly different between the GR and NR. An inverse aberration pattern was also observed between the two extreme response groups at 6p22-p12 for patients in the combination arm. Signs of subclonal reduction were observed, with some aberrations disappearing and others being retained during treatment. Increase in subclonal amplification was observed at 6p21.1, a locus which contains the VEGFA gene for the protein which are targeted by the study drug bevacizumab. Of the 13 pre-treatment samples that had a gain at VEGFA, 12 were responders. Significant decrease of frequency of subclones carrying gains at 17q21.32-q22 was observed at 12 weeks, with the peak occurring at TMEM100, an ALK1 receptor signaling-dependent gene essential for vasculogenesis. This implies that cells bearing amplifications of VEGFA and TMEM100 are particularly sensitive to this treatment regime. CONCLUSIONS: Taken together, these results suggest that heterogeneity and subclonal architecture influence the response to targeted treatment in combination with chemotherapy, with possible implications for clinical decision-making and monitoring of treatment efficacy. TRIAL REGISTRATION: NCT00773695 . Registered 15 October 2008.
45 schema:genre research_article
46 schema:inLanguage en
47 schema:isAccessibleForFree true
48 schema:isPartOf Naf62b61c8af24e55ba5c5e4219f8d976
49 Nf40fcb6bddd3467abb81f9af9e33175d
50 sg:journal.1040124
51 schema:name Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations
52 schema:pagination 92
53 schema:productId N20c727e0e7df4ad49a3d1ddfb267946b
54 N31e6636cc2a94fb98866ef7265b91446
55 N87ff7aafbd274594b1908a0af5e2a27d
56 Ne86e3bba2b4b4db39fceaf8ba66436d7
57 Nebcf7d6ea975455ab685844da545de7b
58 schema:sameAs https://app.dimensions.ai/details/publication/pub.1110268606
59 https://doi.org/10.1186/s13073-018-0601-y
60 schema:sdDatePublished 2019-04-11T12:52
61 schema:sdLicense https://scigraph.springernature.com/explorer/license/
62 schema:sdPublisher N95714545087945d49645dc11aefc6664
63 schema:url https://link.springer.com/10.1186%2Fs13073-018-0601-y
64 sgo:license sg:explorer/license/
65 sgo:sdDataset articles
66 rdf:type schema:ScholarlyArticle
67 N02426503d83d4764aba64906c5867561 rdf:first sg:person.01062455314.30
68 rdf:rest N3486de0db5134451ab78e9db683c6030
69 N0af0a7348492439e8a0d30a17d35b439 rdf:first sg:person.0624011275.27
70 rdf:rest N211e0e44cfca44c9939f0d7c1fa4acf8
71 N1163c144af9a463293713088a30ebf61 rdf:first sg:person.01101476162.97
72 rdf:rest Nf91820a034e64baebda802ed84dc3fab
73 N1a2d6c899d6e4437aa826f9f65b38bbd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
74 schema:name Bevacizumab
75 rdf:type schema:DefinedTerm
76 N20c727e0e7df4ad49a3d1ddfb267946b schema:name dimensions_id
77 schema:value pub.1110268606
78 rdf:type schema:PropertyValue
79 N211e0e44cfca44c9939f0d7c1fa4acf8 rdf:first sg:person.07412247627.28
80 rdf:rest N02426503d83d4764aba64906c5867561
81 N28e7c053ea694182ae00d541ad8cfc1a rdf:first sg:person.01245337432.67
82 rdf:rest Nbacbdd74ff08459fad08ae800f6e30b7
83 N31e6636cc2a94fb98866ef7265b91446 schema:name doi
84 schema:value 10.1186/s13073-018-0601-y
85 rdf:type schema:PropertyValue
86 N337c81c84c3a4a8e8ac73da2ff01a344 schema:name Biomedical Informatics, Department of Informatics and Centre for Cancer Biomedicine, University of Oslo, Oslo, Norway
87 KG Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway
88 rdf:type schema:Organization
89 N33eb901592ab402794857c701df7d797 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Cell Proliferation
91 rdf:type schema:DefinedTerm
92 N3486de0db5134451ab78e9db683c6030 rdf:first sg:person.01050747741.04
93 rdf:rest Nb2573e2f7ee946deb21ca4cd88cf0f8f
94 N3f913dea795640f9a7334bdf50ec5011 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Antineoplastic Combined Chemotherapy Protocols
96 rdf:type schema:DefinedTerm
97 N40db047250cf4819ad60ce5784a7f651 schema:affiliation https://www.grid.ac/institutes/grid.55325.34
98 schema:familyName Gythfeldt
99 schema:givenName Hedda vdL
100 rdf:type schema:Person
101 N51599aaaff1b4b20b37bcd349d19dda4 rdf:first N40db047250cf4819ad60ce5784a7f651
102 rdf:rest N606c8961dd0849758dd7d3c3548a474e
103 N5e12142cf51646608aeeb0fb26daf50b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Angiogenesis Inhibitors
105 rdf:type schema:DefinedTerm
106 N606c8961dd0849758dd7d3c3548a474e rdf:first sg:person.01170302532.43
107 rdf:rest Nf5ed055b3d41402cbe27fdae185aa8b9
108 N8205dc5d61824bf0a56e425cd155d780 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Vascular Endothelial Growth Factor A
110 rdf:type schema:DefinedTerm
111 N86046546508740a1b978c6fab50801b4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Neoadjuvant Therapy
113 rdf:type schema:DefinedTerm
114 N87ff7aafbd274594b1908a0af5e2a27d schema:name nlm_unique_id
115 schema:value 101475844
116 rdf:type schema:PropertyValue
117 N8f1ed808a59e43228fa6c42c5c79bf45 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Genomic Instability
119 rdf:type schema:DefinedTerm
120 N95714545087945d49645dc11aefc6664 schema:name Springer Nature - SN SciGraph project
121 rdf:type schema:Organization
122 N99c0f75b182d4475b0d6447ce70f77e6 rdf:first sg:person.01361622203.97
123 rdf:rest Nb3bf03a01a4e451996ce264c4b0cbf68
124 Na0c7071143f249babc7f12ac9346ce67 rdf:first sg:person.01017630143.46
125 rdf:rest N99c0f75b182d4475b0d6447ce70f77e6
126 Nadb4b45c9db741c19cb007d77826ff1f rdf:first sg:person.01047355062.84
127 rdf:rest N51599aaaff1b4b20b37bcd349d19dda4
128 Naf62b61c8af24e55ba5c5e4219f8d976 schema:issueNumber 1
129 rdf:type schema:PublicationIssue
130 Nb16e70d4515f472ba97c130156228c08 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Breast Neoplasms
132 rdf:type schema:DefinedTerm
133 Nb2573e2f7ee946deb21ca4cd88cf0f8f rdf:first sg:person.01267735562.34
134 rdf:rest N28e7c053ea694182ae00d541ad8cfc1a
135 Nb3bf03a01a4e451996ce264c4b0cbf68 rdf:first sg:person.01002504604.48
136 rdf:rest Ne0a9e997424b48d6a232ad3bd47b6bfe
137 Nbacbdd74ff08459fad08ae800f6e30b7 rdf:first sg:person.01071554513.00
138 rdf:rest Na0c7071143f249babc7f12ac9346ce67
139 Ndc50719933be4635ae18b3102aa1ed8b schema:affiliation https://www.grid.ac/institutes/grid.55325.34
140 schema:familyName Höglander
141 schema:givenName Elen Kristine
142 rdf:type schema:Person
143 Ndd6f211119f0412fade052bcef8b1333 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Humans
145 rdf:type schema:DefinedTerm
146 Ne0a9e997424b48d6a232ad3bd47b6bfe rdf:first sg:person.01215000714.10
147 rdf:rest rdf:nil
148 Ne2baccf3bfe8429688b8816a91832e25 rdf:first sg:person.0707212713.81
149 rdf:rest Nadb4b45c9db741c19cb007d77826ff1f
150 Ne86e3bba2b4b4db39fceaf8ba66436d7 schema:name pubmed_id
151 schema:value 30497530
152 rdf:type schema:PropertyValue
153 Nebcf7d6ea975455ab685844da545de7b schema:name readcube_id
154 schema:value 59796af2b93074086591514be1e031840f09caf58588fc7197ff1ece353ce038
155 rdf:type schema:PropertyValue
156 Nf40fcb6bddd3467abb81f9af9e33175d schema:volumeNumber 10
157 rdf:type schema:PublicationVolume
158 Nf5ed055b3d41402cbe27fdae185aa8b9 rdf:first sg:person.01044522050.07
159 rdf:rest N0af0a7348492439e8a0d30a17d35b439
160 Nf91820a034e64baebda802ed84dc3fab rdf:first sg:person.01252077430.47
161 rdf:rest Ne2baccf3bfe8429688b8816a91832e25
162 Nf9ad958fa8aa4c2dae2a08596873822c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Female
164 rdf:type schema:DefinedTerm
165 Nfdc0c657c8de43b0b90da9ef3dffde48 rdf:first Ndc50719933be4635ae18b3102aa1ed8b
166 rdf:rest N1163c144af9a463293713088a30ebf61
167 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
168 schema:name Medical and Health Sciences
169 rdf:type schema:DefinedTerm
170 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
171 schema:name Oncology and Carcinogenesis
172 rdf:type schema:DefinedTerm
173 sg:journal.1040124 schema:issn 1756-994X
174 schema:name Genome Medicine
175 rdf:type schema:Periodical
176 sg:person.01002504604.48 schema:affiliation https://www.grid.ac/institutes/grid.55325.34
177 schema:familyName Engebraaten
178 schema:givenName Olav
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01002504604.48
180 rdf:type schema:Person
181 sg:person.01017630143.46 schema:affiliation https://www.grid.ac/institutes/grid.451388.3
182 schema:familyName Van Loo
183 schema:givenName Peter
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017630143.46
185 rdf:type schema:Person
186 sg:person.01044522050.07 schema:affiliation https://www.grid.ac/institutes/grid.55325.34
187 schema:familyName Fleischer
188 schema:givenName Thomas
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01044522050.07
190 rdf:type schema:Person
191 sg:person.01047355062.84 schema:affiliation https://www.grid.ac/institutes/grid.55325.34
192 schema:familyName Silwal-Pandit
193 schema:givenName Laxmi
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01047355062.84
195 rdf:type schema:Person
196 sg:person.01050747741.04 schema:affiliation https://www.grid.ac/institutes/grid.55325.34
197 schema:familyName Garred
198 schema:givenName Øystein
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050747741.04
200 rdf:type schema:Person
201 sg:person.01062455314.30 schema:affiliation https://www.grid.ac/institutes/grid.55325.34
202 schema:familyName Borgen
203 schema:givenName Elin
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01062455314.30
205 rdf:type schema:Person
206 sg:person.01071554513.00 schema:affiliation https://www.grid.ac/institutes/grid.55325.34
207 schema:familyName Naume
208 schema:givenName Bjørn
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01071554513.00
210 rdf:type schema:Person
211 sg:person.01101476162.97 schema:affiliation https://www.grid.ac/institutes/grid.55325.34
212 schema:familyName Nord
213 schema:givenName Silje
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01101476162.97
215 rdf:type schema:Person
216 sg:person.01170302532.43 schema:affiliation https://www.grid.ac/institutes/grid.55325.34
217 schema:familyName Vollan
218 schema:givenName Hans Kristian Moen
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01170302532.43
220 rdf:type schema:Person
221 sg:person.01215000714.10 schema:affiliation https://www.grid.ac/institutes/grid.5510.1
222 schema:familyName Kristensen
223 schema:givenName Vessela
224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01215000714.10
225 rdf:type schema:Person
226 sg:person.01245337432.67 schema:affiliation https://www.grid.ac/institutes/grid.55325.34
227 schema:familyName Wist
228 schema:givenName Erik
229 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01245337432.67
230 rdf:type schema:Person
231 sg:person.01252077430.47 schema:affiliation https://www.grid.ac/institutes/grid.4991.5
232 schema:familyName Wedge
233 schema:givenName David C.
234 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01252077430.47
235 rdf:type schema:Person
236 sg:person.01267735562.34 schema:affiliation https://www.grid.ac/institutes/grid.55325.34
237 schema:familyName Holmen
238 schema:givenName Marit M.
239 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01267735562.34
240 rdf:type schema:Person
241 sg:person.01361622203.97 schema:affiliation https://www.grid.ac/institutes/grid.55325.34
242 schema:familyName Børresen-Dale
243 schema:givenName Anne-Lise
244 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01361622203.97
245 rdf:type schema:Person
246 sg:person.0624011275.27 schema:affiliation https://www.grid.ac/institutes/grid.55325.34
247 schema:familyName Krohn
248 schema:givenName Marit
249 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0624011275.27
250 rdf:type schema:Person
251 sg:person.0707212713.81 schema:affiliation N337c81c84c3a4a8e8ac73da2ff01a344
252 schema:familyName Lingjærde
253 schema:givenName Ole Christian
254 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707212713.81
255 rdf:type schema:Person
256 sg:person.07412247627.28 schema:affiliation https://www.grid.ac/institutes/grid.55325.34
257 schema:familyName Schlitchting
258 schema:givenName Ellen
259 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07412247627.28
260 rdf:type schema:Person
261 sg:pub.10.1038/bjc.2013.634 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023376159
262 https://doi.org/10.1038/bjc.2013.634
263 rdf:type schema:CreativeWork
264 sg:pub.10.1038/labinvest.2013.128 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027726525
265 https://doi.org/10.1038/labinvest.2013.128
266 rdf:type schema:CreativeWork
267 sg:pub.10.1038/nature10983 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014607335
268 https://doi.org/10.1038/nature10983
269 rdf:type schema:CreativeWork
270 sg:pub.10.1038/nm.3886 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046110380
271 https://doi.org/10.1038/nm.3886
272 rdf:type schema:CreativeWork
273 sg:pub.10.1038/nrm1357 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052442189
274 https://doi.org/10.1038/nrm1357
275 rdf:type schema:CreativeWork
276 sg:pub.10.1038/sj.bjc.6600210 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010544058
277 https://doi.org/10.1038/sj.bjc.6600210
278 rdf:type schema:CreativeWork
279 sg:pub.10.1038/sj.bjc.6603143 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033429494
280 https://doi.org/10.1038/sj.bjc.6603143
281 rdf:type schema:CreativeWork
282 sg:pub.10.1038/sj.onc.1201380 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038979818
283 https://doi.org/10.1038/sj.onc.1201380
284 rdf:type schema:CreativeWork
285 sg:pub.10.1186/1471-2164-13-591 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010110271
286 https://doi.org/10.1186/1471-2164-13-591
287 rdf:type schema:CreativeWork
288 sg:pub.10.1245/s10434-011-2108-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011255060
289 https://doi.org/10.1245/s10434-011-2108-2
290 rdf:type schema:CreativeWork
291 https://doi.org/10.1016/j.cell.2012.04.023 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012547698
292 rdf:type schema:CreativeWork
293 https://doi.org/10.1016/s0140-6736(03)14023-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017992521
294 rdf:type schema:CreativeWork
295 https://doi.org/10.1056/nejmoa1111097 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014405968
296 rdf:type schema:CreativeWork
297 https://doi.org/10.1073/pnas.1009843107 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007646723
298 rdf:type schema:CreativeWork
299 https://doi.org/10.1093/annonc/mdt361 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014803302
300 rdf:type schema:CreativeWork
301 https://doi.org/10.1093/annonc/mdu118 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015330592
302 rdf:type schema:CreativeWork
303 https://doi.org/10.1096/fj.02-0329fje schema:sameAs https://app.dimensions.ai/details/publication/pub.1030415329
304 rdf:type schema:CreativeWork
305 https://doi.org/10.1097/cad.0b013e32833b7598 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043826280
306 rdf:type schema:CreativeWork
307 https://doi.org/10.1126/science.1136678 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031480762
308 rdf:type schema:CreativeWork
309 https://doi.org/10.1158/1078-0432.ccr-04-2421 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038294800
310 rdf:type schema:CreativeWork
311 https://doi.org/10.1158/1078-0432.ccr-12-3029 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042897668
312 rdf:type schema:CreativeWork
313 https://doi.org/10.1158/1078-0432.ccr-17-0160 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085376969
314 rdf:type schema:CreativeWork
315 https://doi.org/10.1200/jco.1999.17.2.460 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074265640
316 rdf:type schema:CreativeWork
317 https://doi.org/10.1200/jco.2008.18.1370 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045851448
318 rdf:type schema:CreativeWork
319 https://doi.org/10.1200/jco.2014.57.0572 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014185899
320 rdf:type schema:CreativeWork
321 https://doi.org/10.1371/journal.pone.0108405 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029744734
322 rdf:type schema:CreativeWork
323 https://doi.org/10.1383/surg.21.11.272.22295 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014763252
324 rdf:type schema:CreativeWork
325 https://doi.org/10.3892/or.14.2.513 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071529632
326 rdf:type schema:CreativeWork
327 https://www.grid.ac/institutes/grid.451388.3 schema:alternateName The Francis Crick Institute
328 schema:name Cancer Research UK London Research Institute, London, UK
329 rdf:type schema:Organization
330 https://www.grid.ac/institutes/grid.4991.5 schema:alternateName University of Oxford
331 schema:name Big Data Institute, University of Oxford, Oxford, UK
332 rdf:type schema:Organization
333 https://www.grid.ac/institutes/grid.5510.1 schema:alternateName University of Oslo
334 schema:name Department of Clinical Molecular Biology (EpiGen), Divison of Medicine, Akershus University Hospital, Lørenskog, Norway
335 Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Postboks 4953 Nydalen, 0424, Oslo, Norway
336 Institute of Clinical Medicine, University of Oslo, Oslo, Norway
337 KG Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway
338 rdf:type schema:Organization
339 https://www.grid.ac/institutes/grid.55325.34 schema:alternateName Oslo University Hospital
340 schema:name Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Postboks 4953 Nydalen, 0424, Oslo, Norway
341 Department of Oncology, Oslo University Hospital, 0407, Oslo, Norway
342 Department of Pathology, Oslo University Hospital, Oslo, Norway
343 Department of Radiology, Oslo University Hospital, Oslo, Norway
344 KG Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway
345 Section for Breast and Endocrine Surgery, Oslo University Hospital, Oslo, Norway
346 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...